Bills Digest No. 44 2001-02
Taxation Laws Amendment (Research and Development) Bill
2001
WARNING:
This Digest was prepared for debate. It reflects the legislation as
introduced and does not canvass subsequent amendments. This Digest
does not have any official legal status. Other sources should be
consulted to determine the subsequent official status of the
Bill.
CONTENTS
Passage History
Purpose
Background
Main Provisions
Concluding Comments
Endnotes
Contact Officer & Copyright Details
Passage History
Taxation Laws
Amendment (Research and Development) Bill 2001
Date
Introduced: 27 June
2001
House: House of Representatives
Portfolio: Treasury
Commencement: Upon
Royal Assent. However, the measures contained in the Bill have
different application dates, which are set out in the Main
Provisions section of this Digest.
Purpose
To amend the existing 125 per
cent tax concession for research and development (R&D) to:
-
- introduce a premium 175 per cent concession for additional
R&D
-
- introduce a refundable R&D tax offset for small
companies
-
- change the eligibility requirements applicable to R&D
plant, and
-
- tighten the definition of R&D activities.
The Government has two principal ways of encouraging industry to
invest in R&D. The first is via a tax concession under section
73B of the Income Tax Assessment Act 1936 (the Tax Act
1936), and the second is through a scheme of grants made under the
Industry Research and Development Act 1986 (the IR&D
Act). The grants scheme is intended to address gaps in the tax
concession scheme by providing direct assistance to those companies
undertaking R&D activities which cannot take advantage of tax
concessions. (1)
A 150 per cent tax deduction for eligible expenditure on R&D
was introduced by the then Labor Government in May 1986 (commencing
retrospectively from 1 July 1985) as a temporary measure. However,
after various policy changes and consequential amendments to the
legislation, the Labor Government announced in the 1992 93 Budget
speech that the 150 per cent concession would be continued
indefinitely.(2)
In 1996, the new Coalition Government, as part of its Budget
measures on R&D, decided to reduce the maximum concessional
rate of deduction from 150 to 125 per cent. It also tightened the
eligibility criteria for accessing the R&D concession and made
the tax concession unavailable to new syndicates. These measures
were driven by concerns that the R&D tax concession was not tax
effective, that it was not encouraging a significant amount of
R&D that would not have otherwise been undertaken, and that
decisions on investments in R&D were often determined by the
tax consequences of the investment rather than the nature of the
R&D being undertaken.(3)
To ameliorate the changes to the R&D tax concession, the
Coalition also announced in the 1996 Budget the introduction of a
new scheme, the Strategic Assistance for Research and Development
(Start) program. The aim of the Start program is to provide R&D
assistance through a mixture of grants and concessional loans for
R&D projects which have commercial potential and which
generally would otherwise be unlikely to proceed due to lack of
finance.(4) The Industry Research and Development Board
determines who is eligible for funding. The Start program is worth
$1.5 billion over 8 years (1998/99- 2005/06), including $535
million announced in the Innovation Action Plan in January
2001.(5)
In addition to the Start program, Commercialising Emerging
Technologies (COMET) is a new program designed to bolster R&D
investment, and thereby stimulate innovation and business growth,
by providing business advice or assistance to obtain management
qualifications.(6) The COMET program has a budget of up
to $30 million over three years starting from the financial year
1999-2000. An additional funding of $40 million for 2001/02-2004/05
was announced in the Innovation Action Plan.(7)
Business expenditure on research and development (BERD),
expressed as a percentage of gross domestic product (GDP), recorded
a strong upward trend from 1991 92 to 1995 96 but has declined
substantially from 1996-1997.(8) The latest figures show
that this downward trend continued in 1999-2000.(9)
Australia remains thirteenth out of seventeen OECD countries in the
ratio of BERD to GDP. In 1999-2000, Australia s BERD to GDP ratio
was 0.64 per cent, compared with ratios of over 2 per cent in
Finland, Japan and the United States, and between 1 and 2 per cent
in Korea, Germany, France, Denmark, United Kingdom, Netherlands and
Iceland. Moreover this ratio increased in most of these countries
in the preceding two years, in contrast to the decline in
Australia, widening of the already large deficit between BERD in
Australia and that in most other OECD countries.(10)
There has been considerable debate about reasons for this
downturn in BERD in Australia. Many commentators have identified
the lowering of the R&D tax concession in 1996 from 150 to 125
per cent as the major cause of the decline.(11) Although
arguably necessary to remove the tax rorts on the R&D tax
concession, this has effectively reduced the Government subsidy on
R&D from 18 cents in every R&D dollar (23 cents in the
1980s, when the company tax rate was 46 per cent) to nine cents in
every dollar.(12) The Business Council of Australia
estimated from a 1998 survey that R&D spending was one-third or
$1.5 billion lower than it would have been if the previous rate of
growth had been maintained. This suggests that R&D is much more
sensitive to tax concession assistance than earlier studies
indicated.(13) There have also been suggestions that the
administrative costs associated with compliance with the
eligibility criteria are too great to justify to obtain a marginal
benefit of less than 10 per cent.(14)
There has been some speculation that the downward trend may be
bottoming out. The latest figures suggest that, were it not for a
substantial decrease in R&D spending in the mining industry,
BERD may have begun to increase in 2000-2001. R&D expenditure
increased in a number of industries, including the scientific
research, property and business services, finance and insurance
industries.(15) The 2000 01 Budget Papers also indicate
a recent increase in the uptake of the R&D tax concession.
Revenue foregone for the concession increased in 1999 2000 to $553
million and is expected to increase to $600 million in 2000 2001.
This compares with the peak outlay on this concession of $902
million in 1995 96.(16)
There have been no less than three reports in the last two years
recommending a review of Government incentives for business to
conduct R&D.
A 1999 House of Representatives Standing Committee Report on
Australia's R&D concluded that the decrease in BERD from an
already low base ought to be cause for concern.(17) The
Committee recommended that the Government determine an appropriate
policy response to the reduction in BERD from 1996 97 onwards.
Among other measures, it recommended that the National Innovation
Summit consider whether the R&D tax concession should be
restored to 150 per cent, and whether it should be extended to
include up-front payments, equivalent to tax relief, to start-up
companies recording tax losses.(18)
The National Innovation Summit was held in February 2000 in
Melbourne, co-hosted by the Department of Industry, Science and
Resources and the Business Council of Australia. The Final Report
of the Innovation Summit Implementation Group, entitled
Innovation Unlocking the Future, was delivered in August
2000.(19) It contains a number of recommendations
designed to help Australian business and industry develop and use
new ideas and technology. Among other key recommendations aimed at
developing ideas discovered during R&D and encouraging research
in universities, such as by doubling Commonwealth Government
funding for the competitive research grants schemes administered by
the Australian Research Council over a five-year period, the Summit
recommended the Commonwealth Government should:(20)
-
- increase the base rate of the R&D Tax Concession to 130 per
cent
-
- raise the rate of the R&D Tax Concession to between 170 per
cent and 200 per cent for additional R&D over and above a
threshold base. To qualify, businesses would need to increase their
level of R&D by an average of 10 per cent over the identified
base rate determined by, for example, their previous claim history,
and
-
- introduce a cash-out option for small enterprises with a
turnover of less than $1 million and an investment in R&D of
less than $1 million, based on the 130 per cent rate.
The increase in the base rate for the concession to 130 per cent
was recommended to maintain the effective amount of the Government
subsidy once the company tax rate is reduced from 36 per cent to 30
per cent. Although it is estimated to cost $100 million per annum,
this proposal does no more than maintain the amount of support
previously available.(21)
The idea of a cash-out option was intended to provide smaller
businesses with access to cash flow, which can be used to
accelerate growth and increase the amount spent on research and
development. It was estimated this initiative would benefit between
600 and 700 Australian firms.(22)
The Final Report of the Chief Scientist, Dr Robin Batterham,
entitled The Chance to Change, delivered in November 2000,
also adopted some of these recommendations. The Chief Scientist
made recommendations specifically aimed at the commercialisation of
R&D, in addition to recommendations aimed at education and
increased funding for universities and research. Key issues were
the provision of venture capital (that is, capital invested in
start-up companies involved in high technology or innovative
businesses(23)) and the provision of pre-seed capital to
universities, Innovation Centres and government-funded research
agencies such as CSIRO.
Specifically in relation to the R&D tax concession, the
Chief Scientist supported the increase to a base tax concession
rate of 130 per cent, and repeated the call for a cash-out option
for R&D expenditure by smaller businesses. The latter
initiative he claimed would encourage investment in innovation and,
importantly, help expose small and medium-sized enterprises to
innovative activities with reduced financial risk . The Chief
Scientist went further than the National Innovation Summit in
recommending incentives to attract significant R&D projects to
Australia by providing a tax incentive in the order of 200 per cent
or an equivalent incentives package for overseas companies to
locate R&D facilities in Australia.(24)
The Government s response -
Backing Australia s Ability
The Government has responded to these reports by announcing, on
29 January 2001, the Backing Australia s Ability package.
This commits an additional $2.9 billion in Government expenditure
over five years to science, technology and innovation.
Many of the key initiatives provide additional funding for
universities and research institutions.(25) The package
also includes changes to funding for R&D, including continuing
the R&D Start Program (which would otherwise have expired) with
funding of $535 million over five years. In relation to the
R&D tax concession, while the Government has decided not to
implement the recommendation to increase the base rate of the
concession from 125 per cent to 130 per cent (or even, as some
suggested, to 150 per cent), it has heeded the call for a cash
rebate for small companies, particularly those in tax loss.
This Bill implements the following changes to the R&D tax
concession announced in the Backing Australia s Ability
package:(26)
-
- introducing a premium rate of 175 per cent for
additional R&D activity
-
- applying effective-life write off to R&D plant, which will
make the R&D tax concession consistent with the reforms of the
business taxation system
-
- allowing future experimental plant which is also used for
production purposes to receive depreciation deductions at 125 per
cent during the R&D phase, and
-
- introducing a tax rebate for the R&D tax concession for
small companies.
The Government is also introducing changes to tighten the
definition of R&D. This is despite the fact that in 1999 the
House of Representatives Standing Committee on Industry, Science
and Resources recommended that the Government maintain the current
definition of activities eligible for the R&D tax
concession.(27)
In January 2001, the Government estimated that the reform of the
R&D tax concession scheme would cost $115 million over
five years. This has now increased due to a change in the
eligibility rules for the 175 per cent premium tax concession. It
also estimates that over five years up to 1300 small companies that
are in tax loss will get early access to $30 million at a net
cost of $13 million.(28)
A company wishing to claim the R&D tax concession must first
be registered with the Industry Research and Development
Board.(29) The Board determines whether taxpayers
qualify for the 125 per cent R&D tax concession. If the Board
is of the opinion that any of the results of R&D activities
have not been exploited on normal commercial terms, for the benefit
of the Australian economy or that those activities do not have
sufficient Australian content, no deduction is
allowable.(30)
The R&D tax concession is available to companies
incorporated in Australia, and in certain circumstances
partnerships,(31) which are involved in research and
development activities . The definition of research and development
activities is given below. The R&D activities do not have to be
carried on in Australia or in an external
Territory.(32)
Annual eligible R&D expenditure must exceed $20 000 if
the company carries out the R&D itself, to obtain the full 125
per cent deduction. Expenditure below this threshold qualifies for
a 100 per cent tax concession. If R&D is carried on by a
registered research agency (such as the CSIRO) on behalf of a
company or partnership, the $20 000 threshold is waived.
The Bill proposes a number of amendments to the current
situation, which are described below.
New subsection 73B(1AAA) inserts an objects
clause in section 73B of the Tax Act 1936, with effect from Royal
Assent. A similar provision is inserted in the IR&D Act by
new section 39AA. The stated objective is to make
companies which are eligible for the R&D tax deduction more
internationally competitive by:
-
- encouraging them to develop innovative products, processes and
services
-
- increasing their investment in R&D activities
-
- promoting their technological advancement through a focus on
innovation and high technical risk in R&D activities
-
- encouraging them to use strategic R&D planning, and
-
- creating an environment that is conducive to increased
commercialisation of new processes and product technologies
developed by them.
The objects clause goes on to state that the benefits of the tax
incentive are targeted by being limited to particular expenditure
on certain defined activities.
Objects clauses may be used by courts as an aid to
interpretation but are not enforceable. This objects clause makes
clear that the definition of R&D activities is critical to the
availability of the tax deduction, and that not all expenditure on
R&D will be eligible for the concession. The Explanatory
Memorandum explicitly states that the reason for the insertion
of the objects clause is to limit the interpretation of the
definition of R&D activities given by the Administrative
Appeals Tribunal and the Federal Court.(33)
Changes to the definition of R&D
activities
Schedule 1 makes a number of significant
amendments to the definition of R&D activities. Currently,
there are two categories of research and development activities.
These are:
-
- core activities. These are systematic, investigative
or experimental activities that meet one criterion from each of the
following pairs of criteria:
-
- they involve either:
-
-
- innovation (that is, an appreciable element of novelty) or
-
- high levels of technical risk, and
- they are carried on for the purpose of either:
-
-
- acquiring new knowledge, regardless of whether it will have a
specific practical application (this covers basic as well as
applied research(34)) or
-
- creating new or improved materials, products, devices,
processes or services (that is, experimental development), and
- supporting activities. These are activities carried on
for a purpose directly related to the carrying on of core
activities.
Item 3 of Schedule 1 amends the definition of
R&D activities , with effect from 29 January 2001, the date of
the announcement of Backing Australia s Ability. As
described above, currently R&D activities must involve either
innovation or high levels of technical risk. Item
3 amends this, to require that such activities must
henceforth meet both the innovation and high level of
technical risk criteria.
This will mean that not all activities currently eligible for
the R&D tax concession will continue to be eligible.
The Bill also inserts a new condition that all R&D
activities commenced after 29 January 2001 must be carried on in
accordance with an R&D plan (new section
73B(2BA) of the Tax Act 1936). The R&D plan must
comply with guidelines set by the IR&D Board (new
section 39KA of the IR&D Act).
The stated aim of this new requirement is to force companies to
plan R&D activities before incurring expenditure. It is hoped
that this will be a useful tool for the successful management of
R&D projects, providing focus and structure to R&D
activities and thereby enhancing the likelihood of successful
outcomes. (35)
Section 73B(2C) of the Tax Act 1936 currently lists a range of
activities, including market research, prospecting for oil or
minerals, quality control, management studies, patenting and
licensing costs, which are excluded from the definition of core
R&D activities. Item 8 of Schedule 1 extends
that exclusion, so that such activities can no longer be considered
to be supporting activities which are incidental to core R&D.
Thus, from 29 January 2001, no tax deduction will be able to be
claimed in respect of such activities at all. The Explanatory
Memorandum notes that this is because such activities are not
directly related to R&D, but rather relate to post-R&D
production and commercial activities such as sales.(36)
This explanation fails to take into account that some activities,
such as market research, are commonly not post-R&D
activities.
Currently, expenditure on acquiring or constructing plant for
exclusive use in carrying on R&D activities is deductible as
plant expenditure . Plant expenditure is deductible over three
years, and the 125 per cent tax concession applies if the company
spent at least $20 000 on R&D activities in the particular
year. Otherwise, plant expenditure is deductible at 100 per
cent.(37)
Schedule 2 makes three principal amendments to
the treatment of R&D plant in relation to the R&D tax
concession.
Item 1 of Schedule 2 amends the definition of
plant expenditure so that it must be used exclusively for R&D
activities only at least for an initial period . This amendment is
retrospective from 1 July 1985, the date when the R&D tax
concession first became available (item 2). It is
not clear what will constitute an initial period .
This means that plant which is bought or constructed initially
for exclusive use for R&D, and later is used for other
purposes, will remain tax deductible.
As from 21 September 1999, pilot plant (that is, non-commercial
experimental models of plant used in R&D) is retrospectively
made exempt from the application of the capital gains tax
provisions (item 3 of Schedule 2). Thus, any
profit made on the sale or disposal of pilot plant after that time
will not be subject to capital gains tax. This concession will not
apply in 2001 2002 or later years and formalises existing
arrangements.
Where construction was commenced or a contract for purchase or
construction of R&D plant was entered into after 29 January
2001 (item 7 of Schedule 2), plant expenditure
incurred after that time will be subject to an effective life
write-off (new sections 73BG and 73BN of the Tax
Act 1936).(38) Currently, plant expenditure is
deductible over a three year period, which in most cases is shorter
than the effective life of the plant, giving an accelerated rate of
deduction.
The effective life of plant is the length of time for which it
can be used for R&D, assuming reasonable wear and tear, and
assuming it is maintained in good condition. The Commissioner of
Taxation may make a determination specifying the effective life for
a particular item of plant.
Although the period of time over which the tax deduction may be
claimed has been extended, the rate of the deduction remains the
same (new sections 73BA and 73BH of the Tax Act
1936). R&D plant expenditure will continue to be deductible at
125 per cent, provided a company s total expenditure on R&D in
that year exceeds $20 000. Otherwise, the rate of the
deduction will be 100 per cent.
To be eligible for the deduction, a company must be the owner or
quasi-owner of the plant.(39) The company must be
registered with the IR&D Board, and must use the plant for
R&D activities. Certain expenditure, including non-arms length
expenditure and expenditure on activities not which do not meet the
requirements of the IR&D Act, are excluded when either the
Commissioner of Taxation or the IR&D Board so determines
(new sections 73BD and 73BK of the Tax Act 1936).
Special rules apply to determine the percentage contribution to
R&D plant expenditure for each partner in a partnership
(new sections 73BE and 73BL of the Tax Act
1936).
R&D plant, unlike plant used for income-producing purposes,
can include trading stock used for R&D, and capital works (with
the exception of buildings) (new sections 73BB and
73BI of the Tax Act 1936). However, intangible assets are
not included.
Special rules for balancing adjustments currently apply where
R&D plant is disposed of, lost or destroyed. If the value at
the time of disposal is less than the depreciated value of the
R&D plant, the difference is claimable as a deduction. However,
if the value at the time of disposal is more than the depreciated
value of the R&D plant, the difference is taxable as income.
These rules will continue to apply under the new provisions dealing
with R&D plant (new sections 73BF and 73BM of
the Tax Act 1936).
Automatic capital gains tax roll-over relief where R&D plant
is transferred between eligible companies within the same
wholly-owned company group will continue to apply under the new
provisions (new sections 73EA and 73EB of the Tax
Act 1936). The effect of this is that the disposal of R&D plant
to another company within the same group does not incur a capital
gains tax liability, and no balancing adjustment is required to be
made. The company acquiring the R&D plant also inherits the
previous owner s R&D deduction entitlements, and is taken to
have incurred the plant expenditure actually incurred by the
previous owner.
Schedule 3 of the Bill contains amendments
which create a new tax rebate, known as the R&D tax offset.
This is designed to assist small companies, especially those in tax
loss, by giving them the cash equivalent of the R&D tax
concession, thus increasing the cashflow of such companies when
they most need it during their initial growth phase
.(40)
From the first year of income commencing after 30 June 2001
(item 19 of Schedule 3), certain companies will
have the option to choose a tax offset rather than the R&D tax
concession. Whereas the R&D tax concession operates to reduce a
company s taxable income by 125 per cent of the value of
the R&D expenditure, the R&D tax offset will reduce the
amount of income tax payable by a
company.(41)
An eligible company must elect between the R&D tax
concession and the R&D tax offset at the time of submitting the
annual tax return (new subsection 73I(2) of the
Tax Act 1936).
A company is eligible for the R&D tax offset if it meets the
following four criteria (new section 73J of the
Tax Act 1936):
-
- it would be eligible for the R&D tax concession (including
being registered with the IR&D Board)
-
- its total R&D expenditure exceeds $20 000
-
- the total R&D expenditure of the company and other
companies or persons in the group is less than $1 million, and
-
- the R&D turnover of the company and other companies or
persons in the group is less than $5 million.(42)
However, a company will not be eligible for the R&D tax
offset if a tax exempt entity or entities control at least 25 per
cent of the voting power or 25 per cent of the right to
distributions of income or capital (new subsection
73J(2) of the Tax Act 1936).
The amount of the tax offset is 30 per cent of the R&D
concession that would otherwise be available (new
subsection 73I(3) of the Tax Act 1936). Seeing as a
company must spend at least $20 000 on R&D in that year,
the tax offset will be 30 per cent of the 125 per cent R&D tax
concession. Its effective value is thus 37.5 per cent of the total
expenditure on R&D.
The R&D tax offset is refundable to the extent that it
exceeds the amount of income tax payable by a company or entity in
a year (item 13 of Schedule 3).(43)
This represents a significant advantage for companies which have
invested heavily in R&D but either do not make a profit in any
given year or are liable only for a small amount of income tax. The
R&D tax concession is of no or reduced value to such
companies:
Example: If a company makes a tax loss in
a particular year, but incurs $100,000 in R&D expenditure, it
will be eligible to claim the tax offset. The amount of the cash
rebate will be $37,500.
Example: A company s taxable income is
$100,000. At the present rate of company tax of 30 per cent, the
tax payable on $100,000 would be $30,000. Being in a growth and
development phase, the company spent $100,000 on R&D. The
company is not able to take full advantage of the $125,000 R&D
tax concession, as its taxable income is only $100,000. However, if
the company claims the R&D tax offset, this results in a
$37,500 tax rebate. Seeing as the company s total tax liability is
only $30,000, the company would receive a cash refund of
$7,500.
New sections 73L and 73M of the Tax Act 1936
prescribe detailed tests, based on control, for determining when
entities are in the same group. Simplistically, one company
controls another if it has the right to receive more than 50 per
cent of any distribution of capital or income, or has the right to
exercise more than 50 per cent of the voting power in the other
company. There are different rules for control of individuals
companies and fixed trusts, non-fixed trusts, and partnerships. The
stated aim of the grouping rules is to ensure that businesses that
are part of a larger group do not gain access to the tax offset.
(44)
Schedule 4 of the Bill introduces what the
Government refers to as the incremental tax incentive . A 175 per
cent premium tax concession will apply to certain R&D
expenditure (new section 73Y of the Tax Act 1936)
incurred in the first year of income starting after 30 June 2001
(item 11 of Schedule 4).
To be eligible for this premium rate, a company must have been
eligible for the 125 per cent R&D tax concession for four years
running - the current year and the three previous years
(new section 73Q of the Tax Act 1936). This means
the company must either have spent at least $20 000 each of
those four years on R&D, or have paid a registered research
agency to do R&D on its behalf.(45) The company must
also be registered with the IR&D Board in each of those four
years to qualify.(46)
Basically, a company is eligible for the 175 per cent R&D
tax deduction (new subsection 73Y(2) of the Tax
Act 1936) on that portion of its eligible R&D expenditure which
exceeds the average expenditure on R&D over the last three
years. This is called the premium amount (new section
73W of the Tax Act 1936). The premium amount is reduced
slightly if there have been reductions in R&D spending of
greater than 20 per cent in any of the prior three years
(new sections 73T and 73V of the Tax Act
1936).
The Government had initially announced its intention to base the
formula for determining the increase in R&D on research
intensity (basically, R&D spending as a proportion of total
turnover). However, on 23 May 2001 the Government announced the
premium would be calculated more simply, on the increase in R&D
spending.(47) The change is estimated to cost the
Government an extra $80 million over the five year term of the
program.
In calculating whether a company is eligible for the premium 175
per cent rate, not all expenditure is counted. Plant hire or
purchase is excluded,(48) although these expenses are
within the general definition of R&D expenditure eligible for
the 125 per cent concession.(49) Other items which are
excluded from the definition of R&D expenditure and hence are
ineligible for the 125 per cent tax concession will also be
ineligible for the 175 per cent premium. These include expenditure
on core technology, interest, residual feedstock, and the
acquisition or construction of plant or pilot plant:
Example: If a company spends $200,000 on
R&D in a given year, and its average spending over the previous
three years was $150,000, the company will receive the 125 per cent
tax concession on the $150,000, and a 175 per cent deduction for
the additional $50,000. This represents a total tax deduction of
$275,000, compared with $250,000 at the current 125 per cent
rate.
Companies who are eligible to claim the 175 per cent premium tax
concession will be able to choose to take it as a tax offset rather
than a tax deduction, if they meet the eligibility criteria for the
tax offset described above.(50)
Mandatory grouping rules apply to the 175 per cent premium tax
concession. This means that the R&D expenditure of a company
will be considered together with that of all other companies or
entities grouped with it. Whether entities belong to the same group
is determined using the control tests set out in new
section 73L of the Tax Act 1936. The grouping rules are
complex, and include other companies that are grouped with one
company in the group but are not part of the primary group, known
as secondary group members (new section 73R of the
Tax Act 1936). There are also special rules for determining when a
company entered or exited from a group. Where a group of companies
has engaged in R&D spending, the premium amount is divided
between group members in proportion to their contribution to
R&D expenditure (new section 73X of the Tax
Act 1936).
New section 73Z of the Tax Act 1936 introduces
an anti-avoidance measure designed to prevent companies from
adjusting the amount of R&D expenditure in prior years
downwards, so as to increase the difference between their R&D
expenditure history and their expenditure in the current year.
Where the Commissioner of Taxation considers that the purpose of
amending prior year R&D expenditure downwards is to increase
the amount eligible for the 175 per cent premium tax concession, he
or she may disregard the amendment in working out the company s
expenditure which is eligible for the 175 per cent rate.
Items 1 to 4 of Schedule 4 also amend the
clawback provision in section 73C of the Tax Act 1936. The section
currently provides for clawback where a company claims a tax
deduction for R&D expenditure, but later becomes entitled to a
refund or grant covering some or all of that expenditure, to ensure
no doubling up of benefits. The amendments provide that where one
company in a group claims a tax deduction for R&D expenditure,
and another company in the group receives a grant or refund in
relation to that expenditure, for clawback purposes the grant or
refund is taken to have been received by the company which claimed
the tax deduction.
There are two typographical errors in the Bill that have not
been corrected in the amendments tabled in the House of
Representatives on 8 August 2001:
-
- the references in new subsections 73H(1) and
(2) of the Tax Act 1936 to section 72L should instead be
to section 73L (item 5 of Schedule 3), and
-
- item 2 of Schedule 4 should amend paragraph
73C(3)(b) of the Tax Act 1936, not paragraph 73(3)(b) .
Business and industry groups and the research community have
generally welcomed the package of funding measures announced in
Backing Australia s Ability, saying that it represented an
important step towards encouraging innovation and research.
Concerns have, however, been expressed about the changes to the
R&D tax concession. Specific aspects of this are discussed
below.
Changes to the definition of R&D
activities
The changes to the definition of R&D activities have been
introduced because the IR&D Board is concerned that a small
number of claims for the R&D tax concession involve normal
commercial activities rather than R&D. The Government considers
that requiring activities to meet both the innovation and high
degree of technical risk criteria should remove these marginal
claims.(51)
John Schubert, president of the Business Council of Australia,
considers the proposed changes to the eligibility criteria,
together with the changes to the depreciation schedule for R&D
plant, will make the 125 per cent concession less attractive to
business. Steve Batrouney, from Arthur Andersen, agrees that it
will be more difficult for companies to access the 125 per cent
R&D concession, as most firms have traditionally relied on the
criterion of high technical risk rather than innovation. Now, they
will be forced to meet both criteria, and hence to be able to
explain the innovative nature of what they are proposing by
differentiating their research from what others in the same
industry are doing.(52) In addition, they will have to
develop an R&D plan, which will add to the administrative
burden of qualifying for the R&D tax concession, regardless of
the level of expenditure by a business on R&D.
Although the budget statement does not quantify the estimated
savings from the tightening of the definition, some experts claim
it will greatly restrict tax-deduction claims and in some cases
make it difficult to qualify at all. One said it would decimate the
concession but it is hard to know by how much. (53)
However, the Government claims that the vast majority of claims
will not be affected by this change .(54)
The change to effective life write-off for R&D plant, rather
than an accelerated three year write-off, effectively slows the
rate of deductability for expenditure on R&D plant. This
alteration is consistent with the recommendations of the Ralph
Review of Business Taxation, and has already been
implemented, in respect of plant not used for R&D, in the
New Business Tax System (Capital Allowances) Act 2001,
which commenced on 30 June 2001.
The executive director of the Corporate Tax Association, Frank
Drenth, has criticised the proposal to offset profits from
successful plant trials which lead to profitable production against
eligibility for the 125 per cent tax concession, saying: it makes
it awfully difficult to get any benefit from R&D plant now. Why
should you be penalised because you were successful? Jamie Munday,
a partner at Deloitte Touche Tohmatsu, agrees that the change would
reduce the incentive for companies in industries such as
manufacturing or mining to experiment with the development of new
production processes.(55)
Industry groups generally welcomed the introduction of the 175
per cent premium tax concession. The Government s decision to
change the eligibility requirements from a formula based on R&D
as a percentage of turnover, to a formula based on an increase in
the amount of R&D expenditure over a three year period was also
hailed. The former scheme was considered to reward failed
companies, not those who are commercially
successful.(56)
Tax experts at KPMG and Deloitte Touche Tohmatsu said the
premium rate had the potential to provide incentives for some
companies to increase their expenditure on R&D at the right
time in their product development cycles. It also may entice
overseas companies to base more R&D in
Australia.(57)
Problems were nevertheless identified with some specific aspects
of the proposal. Rob Durie, executive director of the Australian
Information Industry Association, said that the requirement for
companies to have a three year claim history of previous R&D
expenditure would still prevent start-up companies from accessing
the concession, as they would not have been in existence for that
length of time.(58) Heather Ridout also described the
continuance of the three-year rule as regrettable
.(59)
Another issue is that the three year average means that each
increase in R&D raises the base average for the following year.
This means that, to continue to be eligible in subsequent years, a
company must continually increase its R&D expenditure compared
to previous years. Some commentators doubt whether companies can
keep increasing R&D expenditure every year, suggesting that a
more sustainable policy would be to encourage companies to maintain
a reasonable level of R&D spending over the long
term.(60)
Finally, the 175 per cent premium concession rate only applies
to labour components of R&D spending, which will advantage
labour-intensive R&D activities but disadvantage researchers
involved in developing prototypes or machinery.(61)
The leader of the Opposition, Kim Beazley, claimed the Howard
Government was merely playing catch-up by restoring some of the
research funding slashed in the 1996 budget.(62) In its
Knowledge Nation platform, the Australian Labor Party has
committed itself to doubling Australia s overall R&D as a
percentage of GDP by 2010, bringing Australia to the top of the
OECD tables (recommendation 3).(63) It has not yet
nominated any specific methods of achieving this, although tax
changes and financial incentives for commercialisation, along with
measures targeted at specific industries, are part of Labor s
preliminary thinking on the issue (recommendations 3 and
4).(64)
The Australian Democrats share the concern to do more to foster
R&D, particularly business investment in R&D. Specifically,
they propose the restoration of the 150 per cent tax deduction for
business R&D, but with the scheme tightened against tax
avoidance abuse. They also wish to promote the commercialisation
of, and business involvement in, Government supported R&D
programs.(65)
In contrast to the disappointment expressed by the business
community, one commentator considers the tightening of the controls
on the R&D tax concession a welcome restraint, and even stated
that the new two-step tax concession for business R&D is too
generous and that governments should be very cautious about trying
to boost the level of private R&D. (66)
Despite enthusiasm for the innovation package generally,
business groups have expressed disappointment with the proposed tax
concessions, saying that the promised tax breaks are largely
negated by the amendments which tighten the definitions and
eligibility requirements. This is seen to reduce the incentive for
investment in innovation and research, and to be building more
speed bumps for investment .(67) One extremely critical
appraisal summed it up thus:(68)
Reduced benefits and unworkable eligibility
rules now stand in stark contrast to the Government s grandstanding
about its desire for businesses to embark on R&D to improve our
products and industries. Instead of making the R&D tax
concession more available to companies, brick walls rather than
hurdles have been placed in front of them, which is likely to
result in R&D expenditure coming to a dead halt for many
companies.
While most commentators from business and industry would not go
as far this, it is clear that the touted benefits are not as great
as they may first seem.(69) The 175 per cent premium tax
incentives for R&D is estimated to cost $540 million over five
years, and the tax offset for small companies is estimated to cost
$13 million over five years. However, $415 million of this will be
offset by planned clawbacks through changes to the depreciation
schedule for R&D plant.(70) There may be further
savings from changes to the eligibility rules for R&D
activities, requiring R&D expenditure to be both innovative and
of high technical risk. Hence, the net benefit to business will be
just $138 million over the five-year life of the package, which
translates to just $27.6 million per year.
Industry groups, while supportive of the broad thrust of the
measures contained in the package, are not confident it will be
enough to reverse the continuing decline in R&D expenditure by
business. John Schubert, president of the Business Council of
Australia, states:(71)
The government should be congratulated for its
response, which has picked up many of the key requirements of a
national innovation strategy. More resources and further
initiatives will be required over time, especially in relation to
commercialisation of research, if the innovation strategy is going
to have the impact required to transform the economy.
Heather Ridout, policy director of the Australian Industry
Group, agrees that although the innovation package would greatly
enhance science, education and the development of knowledge-based
industries, the changes to tax concessions may not be substantial
enough or structured well enough to reverse the decline in R&D
spending by business .(72)
Professor Alan Trounson, a Monash University researcher in the
area of embryonic cells, which contain the promise of eventually
providing treatments for conditions such as Parkinson s disease and
diabetes, emphasises the need to invest in research and its
commercialisation to prevent it from moving overseas. He queries
whether the innovation package will be sufficient, given the
massive investment being made by other countries.
(73)
Business groups emphasise the need for further measures to
effectively encourage innovation and the commercialisation of
research. They continue to call for a return to a tax concession of
150 per cent, as a minimum, saying the current 125 per cent rate is
too low to encourage R&D to the extent required.(74)
It has been noted that with the reduction in the company tax rate
from 34 per cent to 30 per cent, the tax concession needs to be
raised to 130 per cent just to maintain the current 9 cents in the
dollar value of the concession.(75) It has also been
suggested that measures such as tapering capital gains tax rates or
tailored R&D incentives are required to attract investment in
new industries, and provide incentives for large overseas companies
to locate R&D projects in Australia rather than other
countries.(76)
- See Australian Tax Practice, Commentary, Volume 4 at
[73B/1].
- See Australian Tax Practice, Commentary, Volume 4 at
[73B/1].
- See Chris Field, Bills Digest on the Taxation Laws
Amendment Bill (No 3) 1996, Digest No 59 of 1996/97.
- The Start program has five separate components R&D
Start-Core, R&D Start-Plus, R&D Start-Premium, R&D
Start-Graduate and R&D Start-Concessional Loans. R&D
Start-Core provides grants for R&D projects of up to 50% of
eligible project costs for companies with an annual turnover of
less than $50 million in each of the previous three years. R&D
Start-Plus provides grants for R&D projects of up to 20% of
eligible project costs for companies with an annual turnover of $50
million or more. R&D Start-Premium provides a repayable
component which tops up either a Start-Core or a Start-
Plus R&D grant to a maximum of 56.25% of eligible projects
costs. R&D Start-Graduate provides grants to companies with an
annual turnover of less than $50 million in each of the previous
three years to engage a graduate on a R&D related project that
is undertaken in collaboration with a research institution. R&D
Start-Concessional Loans provides assistance of up to 50% of
eligible project costs for companies/groups with fewer than 100
employees for the early commercialisation of technological
innovation of goods, systems or services. See Ausindustry,
R&D Start Program Fact Sheet, http://www.ausindustry.gov.au/documents/dir39/doc536739.pdf
(accessed 31 July 2001).
- See Backing Australia s Ability: Continuation of the
R&D Start Program http://www.isr.gov.au/iap/policy%5Flaunch/templates/facta10.doc
(accessed 13 August 2001); and Backing Australia s Ability: An
Innovation Action Plan for the Future, January 2001, http://www.innovation.gov.au/iap/Policy_Launch/index.html
(accessed 2 August 2001).
- The program offers assistance under two streams. Tailored
Assistance for Commercialisation provides individually tailored
assistance from a Business Adviser developed to meet a client s
specific needs with regard to commercialisation of innovative
products, processes or services. Usually this involves development
of sound management team, business plan, market research and
intellectual property protection required to successfully
commercialise an innovation. Management Skills Development provides
financial assistance for individuals and companies to undertake an
existing program of management development which will enable them
to increase their capacity for innovation and commercialisation.
For more information see the Ausindustry Commercialising
Emerging Technologies (COMET) Fact Sheet, http://www.ausindustry.gov.au/documents/dir13/doc505813.doc
(accessed 2 August 2001).
- Backing Australia s Ability: An Innovation Action Plan for
the Future, January 2001, http://www.innovation.gov.au/iap/Policy_Launch/index.html
(accessed 2 August 2001).
- See Report by the House of Representatives Standing Committee
on Industry, Science and Resources, The Effect of Certain
Public Policy Changes on Australia's R&D, August 1999, pp.
22 24; Business R&D continues to fall ABS survey , Media
Release, 4 June 1999.
- Australian Bureau of Statistics, Research and Development,
Businesses Australia 1999-2000, 11 July 2001 (8104.0).
- See also Simon Grose, Figures show spending on research may be
creeping upwards after steady falls Canberra Times, 14
July 2001, Greg Baker and Mike Emmery, The Performance Record
of Australian Manufacturing, Research Paper, No. 22 of
1999/2000, 6 June 2000.
- Cited in Report by the House of Representatives Standing
Committee on Industry, Science and Resources, The Effect of
Certain Public Policy Changes on Australia's R&D, August
1999, pp. 94 97.
- Greg Baker and Mike Emmery, The Performance Record of
Australian Manufacturing, Research Paper, No 22 of 1999/2000,
6 June 2000.
- James Kirby, 'Lights go out in research labs', Business
Review Weekly, 13 July 1998.
- Report by the House of Representatives Standing Committee on
Industry, Science and Resources, The Effect of Certain Public
Policy Changes on Australia's R&D, August 1999, p.
96.
- Australian Bureau of Statistics, Research and Development,
Businesses Australia 1999-2000, 11 July 2001 (8104.0), p. 5.
See also Simon Grose, Figures show spending on research may be
creeping upwards after steady falls Canberra Times, 14
July 2001.
- Science and Technology Budget Statement 2000
01, Table 3, p. 89. The statement may be found at http://www.isr.gov.au/science/analysis/Budget2000/statement.pdf
(accessed 15 August 2001).
- Report by the House of Representatives Standing Committee on
Industry, Science and Resources, The Effect of Certain Public
Policy Changes on Australia's R&D, August 1999, p.
24.
- Report by the House of Representatives Standing Committee on
Industry, Science and Resources, The Effect of Certain Public
Policy Changes on Australia's R&D, August 1999, p.
98.
- It can be found at http://www.isr.gov.au/industry/summit/isigreport.pdf
(accessed 2 August 2001).
- Final Report of the Innovation Summit Implementation Group,
Innovation Unlocking the Future, August 2000, p.
xiii.
- Final Report of the Innovation Summit Implementation Group,
Innovation Unlocking the Future, August 2000, p. 14.
- Ibid., p. 14.
- Recent measures the Government has taken to encourage venture
capital include the Innovation Investment Fund program, the Pooled
Development Fund program, targetted capital gains tax relief, the
collective investment vehicles regime, and scrip for scrip rollover
relief. For more information see Final Report of the Chief
Scientist, Dr Robin Batterham, The Chance to Change,
November 2000, p. 83.
- Final Report of the Chief Scientist, Dr Robin Batterham,
The Chance to Change, November 2000, p. 86 87. http://www.innovation.gov.au/science/review/ChanceFinal.pdf
(accessed 2 August 2001).
- These include: money to foster scientific, mathematical and
technological skills and innovation in government schools, funding
2000 additional university places each year, with priority given to
information and communications technology, mathematics and science,
doubling the funding available for Australian Research Council
competitive grants, boosting research infrastructure funding, a
commitment to funding for world class centres of excellence in
information and communications technologies and biotechnology, and
support for investments in major national research facilities.
- Backing Australia s Ability: An Innovation Action Plan for
the Future, January 2001, http://www.innovation.gov.au/iap/Policy_Launch/index.html
(accessed 2 August 2001).
- Report by the House of Representatives Standing Committee on
Industry, Science and Resources, The Effect of Certain Public
Policy Changes on Australia's R&D, August 1999, p.
101.
- Backing Australia s Ability: An Innovation Action Plan for
the Future, January 2001.
- Section 39J of the IR&D Act.
- A certificate is issued to the Commissioner of Taxation under
section 39M of the IR&D Act.
- Subsection 73B(3A) of the Tax Act 1936 sets out when a
partnership is eligible.
- Section 39EB of the IR&D Act sets out the guidelines
relating to expenditure on overseas R&D activities. Section
39EB(3)(c) further provides that expenditure incurred in respect of
the overseas component of R&D activities must not exceed 10 per
cent of the total expenditure that the company has incurred or
proposes to incur on the project of R&D activities.
- Explanatory Memorandum, p. 6.
- Basic research is experimental or theoretical work
undertaken primarily to acquire new knowledge of the underlying
foundations of phenomena, and observable facts, without any
particular application or use in view. Applied research is
work undertaken for the advancement of knowledge with a specific
practical application in view. It involves consideration of the
available knowledge and its extension in order to solve particular
problems, and to develop ideas into operational form.
- Department of Industry, Science and Resources, Backing
Australia s Ability Fact Sheet, Questions and Answers The
definition of R&D activities,
http://www.innovation.gov.au/iap/policy_launch/templates/definition.doc?Ois=y;template=inntem.html
(accessed 3 August 2001).
- Explanatory Memorandum, p. 7.
- See subsection 73B(15) of the Tax Act 1936.
- There are two section references for each measure relating to
the effective life write-off for R&D plant, because there are
two sets of amendments. Transitional amendments apply for the
period from 29 January 2001 to 30 June 2001. Their treatment of
R&D plant expenditure is based on Division 42 of the Income
Tax Assessment Act 1997 (Tax Act 1997). Division 42 was
repealed on 30 June 2001 by the New Business Tax System
(Capital Allowances) Act 2001, and its provisions incorporated
into the new Division 40 of the Tax Act 1997. Accordingly, the
provisions dealing with R&D plant expenditure after 30 June
2001 are based on the provisions of Division 40. The two sets of
amendments generally parallel each other.
- New sections 73BC and 73BJ of the Tax Act 1936
refer to sections 40-25 and 42-15 of the Tax Act 1997 respectively,
which require a person to be the owner or quasi-owner of plant to
claim a deduction.
- The Hon. Warren Entsch, MP, second reading speech on the
Taxation Laws Amendment (Research and Development) Bill 2001, House
of Representatives, Hansard, 27 June 2001, p. 28647.
- See the definition of tax offset in section 4-10 of the Tax Act
1997.
- R&D group turnover is defined in new section
73K. It includes the turnover of other companies or
entities in the group. It also includes gambling supplies, but
excludes insurance payouts under an insurance policy and loan
repayments.
- See sections 67 30 and 67 35 of the Tax Act 1997.
- Explanatory Memorandum, p. 24.
- See subsections 73B(13) and (14) of the Tax Act 1936. A company
also becomes eligible for the 125 per cent tax concession where it
has paid money to the Coal Research Trust Account, which then funds
the performance of R&D for the company. Unlike R&D
conducted by the company itself, no $20 000 threshold applies
to payments to a research agency or the Coal Research Trust
Account.
- Subsection 73B(10) of the Tax Act 1936.
- Department of Industry, Science and Resources, Backing
Australia s Ability Fact Sheet, Questions and Answers The
175% Premium R&D Tax Concession,
http://www.innovation.gov.au/iap/policy_launch/templates/premium.doc?Ois=y;template=inntem.html
(accessed 3 August 2001).
- See the definition of incremental expenditure in new
section 73P.
- Subsection 73B(1) of the Tax Act 1936.
- See Department of Industry, Science and Resources, Backing
Australia s Ability Fact Sheet, Additional Questions and
Answers The 175% Premium R&D Tax Concession.
- Department of Industry, Science and Resources, Backing
Australia s Ability Fact Sheet, Questions and Answers The
definition of R&D activities.
- Tom Skotnicki, A little help, a little hindrance , Business
Review Weekly, 2 February 2001
- R&D scheme heads for failure , Financial Review, 3
February 2001.
- Department of Industry, Science and Resources, Backing
Australia s Ability Fact Sheet, Questions and Answers The
definition of R&D activities.
- Allesandra Fabro, Bill s fine print reveals erosion of R&D
concession , Financial Review, 3 August 2001.
- See R&D scheme heads for failure , Financial
Review, 3 February 2001.
- John Rouw, Doubts on research tax breaks , The Age, 30
January 2001.
- Selina Mitchell and Stephen Brook, Start-ups won t benefit ,
The Australian, 29 May 2001.
- Selina Mitchell and Stephen Brook, Start-ups won t benefit ,
The Australian, 29 May 2001.
- R&D scheme heads for failure , Financial Review, 3
February 2001.
- Mike Bannon, Deduction for crucial R&D wound back another
notch , Canberra Times, 25 March 2001.
- Reported in Louise Dodson and Tim Colebatch, Unis hail research
boost , The Age, 30 January 2001.
- The Hon Kim Beazley, MP, Opening Remarks at the Acceptance
of the Report of the Knowledge Nation Taskforce, 2 July
2001.
- Knowledge Nation, http://www.alp.org.au/kn/kn_recs_020701.html
(accessed 14 August 2001).
- Australian Democrats, Issue Sheet 98, Trade and Industry:
Research and Development, http://www.democrats.org.au/issue/tiresearch.htm
(accessed 14 August 2001).
- Alan Mitchell, Howard s innovation pitch: The initiative seems
money well spent , Financial Review, 30 January 2001.
- Tom Skotnicki, A little help, a little hindrance , Business
Review Weekly, 2 February 2001.
- Mike Bannon, Deduction for crucial R&D wound back another
notch , Canberra Times, 25 March 2001.
- See Louise Dodson and Tim Colebatch, Unis hail research boost ,
The Age, 30 January 2001, Tom Skotnicki, A little help, a
little hindrance , Business Review Weekly, 2 February
2001, John Rouw, Doubts on research tax breaks , The Age,
30 January 2001, R&D scheme heads for failure , Financial
Review, 3 February 2001.
- Explanatory Memorandum, p. 48.
- Innovation package good step but tax problems: BCA ,
I.T.,
29 January 2001
- Reported in Louise Dodson and Tim Colebatch, Unis hail research
boost , The Age, 30 January 2001.
- Tom Skotnicki, A little help, a little hindrance , Business
Review Weekly, 2 February 2001
- Selina Mitchell and Stephen Brook, Start-ups won t benefit ,
The Australian, 29 May 2001.
- Mike Bannon, Deduction for crucial R&D wound back another
notch , Canberra Times, 25 March 2001.
- Ken Baldwin, More bucks for our technological bang , The
Australian, 31 January 2001.
Katrine Del Villar
10 September 2001
Bills Digest Service
Information and Research Services
This paper has been prepared for general distribution to
Senators and Members of the Australian Parliament. While great care
is taken to ensure that the paper is accurate and balanced, the
paper is written using information publicly available at the time
of production. The views expressed are those of the author and
should not be attributed to the Information and Research Services
(IRS). Advice on legislation or legal policy issues contained in
this paper is provided for use in parliamentary debate and for
related parliamentary purposes. This paper is not professional
legal opinion. Readers are reminded that the paper is not an
official parliamentary or Australian government document.
IRS staff are available to discuss the paper's
contents with Senators and Members and their staff but not with
members of the public.
ISSN 1328-8091
© Commonwealth of Australia 2002
Except to the extent of the uses permitted under the
Copyright Act 1968, no part of this publication may be
reproduced or transmitted in any form or by any means, including
information storage and retrieval systems, without the prior
written consent of the Parliamentary Library, other than by Members
of the Australian Parliament in the course of their official
duties.
Published by the Department of the Parliamentary Library,
2002.
Back to top